{
    "clinical_study": {
        "@rank": "69010", 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the safety and efficacy of flupenthixol decanoate\n      for treatment of methamphetamine dependence.  Also, study will compare flupenthixol with\n      desipramine in blocking methamphetamine self-administration."
        }, 
        "brief_title": "Flupenthixol Decanoate in Methamphetamine Smoking - 1", 
        "completion_date": "May 1996", 
        "condition": "Substance-Related Disorders", 
        "condition_browse": {
            "mesh_term": "Substance-Related Disorders"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Please contact site for information."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "22 Years"
        }, 
        "enrollment": "58", 
        "firstreceived_date": "September 20, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000241", 
            "org_study_id": "NIDA-07200-1", 
            "secondary_id": "R01-07200-1"
        }, 
        "intervention": {
            "intervention_name": "Flupenthixol", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Flupenthixol", 
                "Flupenthixol decanoate", 
                "Methamphetamine"
            ]
        }, 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "Los Angeles", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "90025"
                }, 
                "name": "Friends Research Institute"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Flupenthixol Decanoate in Methamphetamine Smoking", 
        "overall_official": {
            "affiliation": "Friends Research Institute, Inc.", 
            "last_name": "Frank Gawin, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "primary_outcome": {
            "measure": "Methamphetamine use"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000241"
        }, 
        "source": "National Institute on Drug Abuse (NIDA)", 
        "sponsors": {
            "collaborator": {
                "agency": "Friends Research Institute, Inc.", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "February 1994", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 1994"
    }, 
    "geocoordinates": {
        "Friends Research Institute": "34.052 -118.244"
    }
}